BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazuski JE, Sawyer RG, Nathens AB, Dipiro JT, Schein M, Kudsk KA, Yowler C. The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: Evidence for the Recommendations. Surgical Infections 2002;3:175-233. [DOI: 10.1089/109629602761624180] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Fontela PS, Quach C, Karim ME, Willson DF, Gilfoyle E, McNally JD, Gonzales M, Papenburg J, Reynolds S, Lacroix J; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network., Canadian Critical Care Trials Group. Determinants of Antibiotic Tailoring in Pediatric Intensive Care: A National Survey. Pediatr Crit Care Med 2017;18:e395-405. [PMID: 28661973 DOI: 10.1097/PCC.0000000000001238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Riccio LM, Popovsky KA, Hranjec T, Politano AD, Rosenberger LH, Tura KC, Sawyer RG. Association of excessive duration of antibiotic therapy for intra-abdominal infection with subsequent extra-abdominal infection and death: a study of 2,552 consecutive infections. Surg Infect (Larchmt) 2014;15:417-24. [PMID: 24824591 DOI: 10.1089/sur.2012.077] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
3 Sanabria A. Decision-Making Analysis for Selection of Antibiotic Treatment in Intra-Abdominal Infection Using Preference Measurements. Surgical Infections 2006;7:453-62. [DOI: 10.1089/sur.2006.7.453] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
4 Seguin P, Verdier MC, Chanavaz C, Engrand C, Laviolle B, Donnio PY, Mallédant Y. Plasma and peritoneal concentration following continuous infusion of cefotaxime in patients with secondary peritonitis. J Antimicrob Chemother 2009;63:564-7. [PMID: 19168542 DOI: 10.1093/jac/dkn522] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
5 Wang Y, Guo J, Xiong T, Wang F, Kou G, Ning H. The quality assessment of intraabdominal infection guidelines/consensuses in 2 decades - which are better and any changes? Medicine (Baltimore) 2020;99:e23643. [PMID: 33327344 DOI: 10.1097/MD.0000000000023643] [Reference Citation Analysis]
6 Rajput D, Gupta A, Kumar S, Singla T, Srikanth K, Chennatt J. Clinical spectrum and management outcome in gallbladder perforation-a sinister entity: Retrospective study from Sub-Himalayan region of India. Turk J Surg 2022;38:25-35. [DOI: 10.47717/turkjsurg.2022.5325] [Reference Citation Analysis]
7 Hedrick TL, Smith PW, Gazoni LM, Sawyer RG. The Appropriate Use of Antibiotics in Surgery: A Review of Surgical Infections. Current Problems in Surgery 2007;44:635-75. [DOI: 10.1067/j.cpsurg.2007.06.006] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
8 de Korte N, Unlü C, Boermeester MA, Cuesta MA, Vrouenreats BC, Stockmann HB. Use of antibiotics in uncomplicated diverticulitis. Br J Surg. 2011;98:761-767. [PMID: 21523694 DOI: 10.1002/bjs.7376] [Cited by in Crossref: 38] [Cited by in F6Publishing: 27] [Article Influence: 3.5] [Reference Citation Analysis]
9 Cat TB, Charash W, Hebert J, Marden BT, Corbett SM, Ahern J, Rebuck JA. Potential influence of antisecretory therapy on the development of Candida-associated intraabdominal infection. Ann Pharmacother 2008;42:185-91. [PMID: 18212256 DOI: 10.1345/aph.1K328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 Mazuski JE, Sawyer RG, Nathens AB, Dipiro JT, Schein M, Kudsk KA, Yowler C. The Surgical Infection Society Guidelines on Antimicrobial Therapy for Intra-Abdominal Infections: An Executive Summary. Surgical Infections 2002;3:161-73. [DOI: 10.1089/109629602761624171] [Cited by in Crossref: 152] [Cited by in F6Publishing: 123] [Article Influence: 7.6] [Reference Citation Analysis]
11 Tang H, Lu W, Yang Z, Jiang K, Chen Y, Lu S, Dong J. Risk factors and long-term outcome for postoperative intra-abdominal infection after hepatectomy for hepatocellular carcinoma. Medicine (Baltimore) 2017;96:e6795. [PMID: 28445320 DOI: 10.1097/MD.0000000000006795] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
12 Mallick R, Sun S, Schell SR. Predictors of efficacy and health resource utilization in treatment of complicated intra-abdominal infections: evidence for pooled clinical studies comparing tigecycline with imipenem-cilastatin. Surg Infect (Larchmt) 2007;8:159-72. [PMID: 17437361 DOI: 10.1089/sur.2005.058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
13 Pieracci FM, Barie PS. Management of Severe Sepsis of Abdominal Origin. Scand J Surg 2007;96:184-96. [DOI: 10.1177/145749690709600302] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 10.5] [Reference Citation Analysis]
14 Cheadle W, Lee JT, Napolitano LM, Nichols RL. Clinical Update on the Use of Moxifloxacin in the Treatment of Community-Acquired Complicated Intraabdominal Infections. Surgical Infections 2010;11:487-94. [DOI: 10.1089/sur.2009.062] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
15 Peterson L. Currently available antimicrobial agents and their potential for use as monotherapy. Clinical Microbiology and Infection 2008;14:30-45. [DOI: 10.1111/j.1469-0691.2008.02125.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
16 Abad CL, Kumar A, Safdar N. Antimicrobial therapy of sepsis and septic shock--when are two drugs better than one? Crit Care Clin 2011;27:e1-27. [PMID: 21440195 DOI: 10.1016/j.ccc.2010.12.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
17 Barie PS, Hydo LJ, Eachempati SR. Longitudinal outcomes of intra-abdominal infection complicated by critical illness. Surg Infect (Larchmt) 2004;5:365-73. [PMID: 15744128 DOI: 10.1089/sur.2004.5.365] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
18 Piccoli M, Agresta F, Attinà GM, Amabile D, Marchi D; “Complex abdominal wall study” Italian Collaborative Group. "Complex abdominal wall" management: evidence-based guidelines of the Italian Consensus Conference. Updates Surg 2019;71:255-72. [PMID: 30255435 DOI: 10.1007/s13304-018-0577-6] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
19 Spirt MJ. Complicated intra-abdominal infections: a focus on appendicitis and diverticulitis. Postgrad Med 2010;122:39-51. [PMID: 20107288 DOI: 10.3810/pgm.2010.01.2098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Slieker JC, Aellen S, Eggimann P, Guarnero V, Schäfer M, Demartines N. Procalcitonin-Guided Antibiotics after Surgery for Peritonitis: A Randomized Controlled Study. Gastroenterol Res Pract 2017;2017:3457614. [PMID: 28607552 DOI: 10.1155/2017/3457614] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
21 Wong PF, Gilliam AD, Kumar S, Shenfine J, O'Dair GN, Leaper DJ. Antibiotic regimens for secondary peritonitis of gastrointestinal origin in adults. Cochrane Database Syst Rev. 2005;CD004539. [PMID: 15846719 DOI: 10.1002/14651858.cd004539.pub2] [Cited by in Crossref: 37] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
22 Lam SW, Eschenauer GA, Carver PL. Evolving role of early antifungals in the adult intensive care unit. Crit Care Med 2009;37:1580-93. [PMID: 19325484 DOI: 10.1097/CCM.0b013e31819dec9b] [Cited by in Crossref: 22] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
23 Dutton WD, Diaz JJ Jr, Miller RS. Critical care issues in managing complex open abdominal wound. J Intensive Care Med 2012;27:161-71. [PMID: 21436165 DOI: 10.1177/0885066610396162] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
24 Wu X, Wu J, Wang P, Fang X, Yu Y, Tang J, Xiao Y, Wang M, Li S, Zhang Y, Hu B, Ma T, Li Q, Wang Z, Wu A, Liu C, Dai M, Ma X, Yi H, Kang Y, Wang D, Han G, Zhang P, Wang J, Yuan Y, Wang D, Wang J, Zhou Z, Ren Z, Liu Y, Guan X, Ren J. Diagnosis and Management of Intraabdominal Infection: Guidelines by the Chinese Society of Surgical Infection and Intensive Care and the Chinese College of Gastrointestinal Fistula Surgeons. Clin Infect Dis 2020;71:S337-62. [PMID: 33367581 DOI: 10.1093/cid/ciaa1513] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Swenson BR, Metzger R, Hedrick TL, McElearney ST, Evans HL, Smith RL, Chong TW, Popovsky KA, Pruett TL, Sawyer RG. Choosing antibiotics for intra-abdominal infections: what do we mean by "high risk"? Surg Infect (Larchmt) 2009;10:29-39. [PMID: 19226202 DOI: 10.1089/sur.2007.041] [Cited by in Crossref: 64] [Cited by in F6Publishing: 56] [Article Influence: 4.9] [Reference Citation Analysis]
26 Chandra A, Dhar P, Dharap S, Goel A, Gupta R, Hardikar JV, Kapoor VK, Mathur AK, Modi P, Narwaria M, Ramesh MK, Ramesh H, Sastry R, Shah S, Virk S, Sudheer OV, Sreevathsa MR, Varshney S, Kochhar P, Somasundaram S, Desai C, Schou M; Mascot Study Group. Cefoperazone-Sulbactam for Treatment of Intra-Abdominal Infections: Results from a Randomized, Parallel Group Study in India. Surgical Infections 2008;9:367-76. [DOI: 10.1089/sur.2007.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
27 Chow AW, Evans GA, Nathens AB, Ball CG, Hansen G, Harding GK, Kirkpatrick AW, Weiss K, Zhanel GG. Canadian practice guidelines for surgical intra-abdominal infections. Can J Infect Dis Med Microbiol 2010;21:11-37. [PMID: 21358883 DOI: 10.1155/2010/580340] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
28 Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Surg Infect (Larchmt). 2010;11:79-109. [PMID: 20163262 DOI: 10.1089/sur.2009.9930] [Cited by in Crossref: 284] [Cited by in F6Publishing: 233] [Article Influence: 23.7] [Reference Citation Analysis]
29 Tellado JM. The Need for New Antimicrobials for Intra-Abdominal Infections (IAI): Defining the Forthcoming Scenario. Surgical Infections 2006;7:1-4. [DOI: 10.1089/sur.2006.7.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
30 Byrnes MC, Schuerer DJE, Schallom ME, Sona CS, Mazuski JE, Taylor BE, Mckenzie W, Thomas JM, Emerson JS, Nemeth JL, Bailey RA, Boyle WA, Buchman TG, Coopersmith CM. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices: . Critical Care Medicine 2009;37:2775-81. [DOI: 10.1097/00003246-200910000-00015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 0.9] [Reference Citation Analysis]
31 Peterson LR. A review of tigecycline--the first glycylcycline. Int J Antimicrob Agents 2008;32 Suppl 4:S215-22. [PMID: 19134522 DOI: 10.1016/S0924-8579(09)70005-6] [Cited by in Crossref: 86] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
32 Darkahi B, Sandblom G, Liljeholm H, Videhult P, Melhus Å, Rasmussen IC. Biliary microflora in patients undergoing cholecystectomy. Surg Infect (Larchmt) 2014;15:262-5. [PMID: 24801654 DOI: 10.1089/sur.2012.125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
33 Lee M, Izzy M, Ho S. Novel use of fully covered self-expandable metal stent for drainage of perirectal abscess. A case series. Arab J Gastroenterol 2017;18:122-5. [PMID: 28624158 DOI: 10.1016/j.ajg.2017.05.017] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Aarts MW, Granton J, Cook DJ, Bohnen JM, Marshall JC. Empiric Antimicrobial Therapy in Critical Illness: Results of a Surgical Infection Society Survey. Surgical Infections 2007;8:329-36. [DOI: 10.1089/sur.2006.072] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
35 Malangoni MA, Song J, Herrington J, Choudhri S, Pertel P. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann Surg 2006;244:204-11. [PMID: 16858182 DOI: 10.1097/01.sla.0000230024.84190.a8] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 5.1] [Reference Citation Analysis]
36 Jang JY, Kang WS, Keum MA, Sul YH, Lee DS, Cho H, Lee GJ, Lee JG, Hong SK; Korean Society of Acute Care Surgery (KSACS) Clinical Research Group. Antibiotic use in patients with abdominal injuries: guideline by the Korean Society of Acute Care Surgery. Ann Surg Treat Res 2019;96:1-7. [PMID: 30603627 DOI: 10.4174/astr.2019.96.1.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Hylander Møller M, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med 2021;49:e1063-143. [PMID: 34605781 DOI: 10.1097/CCM.0000000000005337] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
38 Caínzos M. Review of the guidelines for complicated skin and soft tissue infections and intra-abdominal infections--are they applicable today? Clin Microbiol Infect 2008;14 Suppl 6:9-18. [PMID: 19040462 DOI: 10.1111/j.1469-0691.2008.02123.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
39 Vu LT, Nobuhara KK, Lee H, Farmer DL. Conflicts in wound classification of neonatal operations. J Pediatr Surg 2009;44:1206-11. [PMID: 19524742 DOI: 10.1016/j.jpedsurg.2009.02.026] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
40 Batyrshin IM, Shlyapnikov SA, Demko AE, Ostroumova YS, Sklizkov DS, Fomin DV, Tishkov AV, Strakh LV. [Prediction and differentiated approach in the treatment of patients with secondary peritonitis and abdominal sepsis]. Khirurgiia (Mosk) 2020;:27-33. [PMID: 32500686 DOI: 10.17116/hirurgia202005127] [Reference Citation Analysis]
41 Kujath P, Hoffmann M, Rodloff A. Antibiotika- und Pilztherapie bei intraabdominellen Infektionen. Chirurg 2008;79:295-305. [DOI: 10.1007/s00104-008-1484-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
42 Hsueh PR, Liu CY, Shi ZY, Lee MH, Chang FY, Yang MC. Cost minimisation analysis of antimicrobial treatment for intra-abdominal infections: a multicentre retrospective study from Taiwan. Int J Antimicrob Agents 2010;35:94-6. [PMID: 19889518 DOI: 10.1016/j.ijantimicag.2009.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
43 Oñate J, Pallares Gutiérrez CJ, Esparza G, Jimenez A, Berrio Medina I, Osorio-pinzón J, Cataño J, Alvarez- Moreno C, Rodriguez J, Guevara F, Mercado M, Zuluaga M, Becerra JS, Alvarez M, Coronel W, Ordonez K, Villegas M. Consensus Recommendations Based on Evidence for Abdominal Sepsis in the Pediatric and Adult Population of Colombia. Infect 2021;25:212. [DOI: 10.22354/in.v25i4.954] [Reference Citation Analysis]
44 Seitz M, Schlenker B, Stief C. Acute Postoperative Complications. In: Hohenfellner M, Santucci RA, editors. Emergencies in Urology. Berlin: Springer Berlin Heidelberg; 2007. pp. 364-429. [DOI: 10.1007/978-3-540-48605-3_29] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Solomkin JS, Mazuski J. Intra-abdominal Sepsis: Newer Interventional and Antimicrobial Therapies. Infectious Disease Clinics of North America 2009;23:593-608. [DOI: 10.1016/j.idc.2009.04.007] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
46 Barie PS, Hydo LJ, Shou J, Larone DH, Eachempati SR. Influence of antibiotic therapy on mortality of critical surgical illness caused or complicated by infection. Surg Infect (Larchmt) 2005;6:41-54. [PMID: 15865550 DOI: 10.1089/sur.2005.6.41] [Cited by in Crossref: 89] [Cited by in F6Publishing: 76] [Article Influence: 5.2] [Reference Citation Analysis]
47 Barie PS. The cost of failure. Surg Infect (Larchmt) 2008;9:313-5. [PMID: 18570572 DOI: 10.1089/sur.2007.9964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
48 Laterre PF. Progress in medical management of intra-abdominal infection. Curr Opin Infect Dis 2008;21:393-8. [PMID: 18594292 DOI: 10.1097/QCO.0b013e328306ef2a] [Cited by in Crossref: 9] [Article Influence: 0.6] [Reference Citation Analysis]
49 Cheadle WG, Spain DA. The continuing challenge of intra-abdominal infection. The American Journal of Surgery 2003;186:15-22. [DOI: 10.1016/j.amjsurg.2003.10.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
50 Byrnes MC, Mazuski JE. Antimicrobial Therapy for Acute Colonic Diverticulitis. Surgical Infections 2009;10:143-54. [DOI: 10.1089/sur.2007.087] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
51 Dominguez EA. Single-Agent Therapy With Tigecycline in the Treatment of Complicated Skin and Skin Structure and Complicated Intraabdominal Infections. Infectious Diseases in Clinical Practice 2009;17:144-9. [DOI: 10.1097/ipc.0b013e31819b894d] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
52 Graham KA, Laituri CA, Markel TA, Ladd AP. A review of postoperative feeding regimens in infantile hypertrophic pyloric stenosis. Journal of Pediatric Surgery 2013;48:2175-9. [DOI: 10.1016/j.jpedsurg.2013.04.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
53 Mazuski JE. Antimicrobial treatment for intra-abdominal infections. Expert Opin Pharmacother 2007;8:2933-45. [PMID: 18001254 DOI: 10.1517/14656566.8.17.2933] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
54 Mazuski JE, Solomkin JS. Intra-Abdominal Infections. Surgical Clinics of North America 2009;89:421-37. [DOI: 10.1016/j.suc.2008.12.001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 39] [Article Influence: 5.4] [Reference Citation Analysis]
55 Lee JT. Nomenclature Nightmare. Surgical Infections 2003;4:293-6. [DOI: 10.1089/109629603322761346] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
56 Pieracci FM, Barie PS. Intra-abdominal infections: . Current Opinion in Critical Care 2007;13:440-9. [DOI: 10.1097/mcc.0b013e32825a6720] [Cited by in Crossref: 26] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
57 Seguin P, Fédun Y, Laviolle B, Nesseler N, Donnio PY, Mallédant Y. Risk factors for multidrug-resistant bacteria in patients with post-operative peritonitis requiring intensive care. J Antimicrob Chemother. 2010;65:342-346. [PMID: 20008043 DOI: 10.1093/jac/dkp439] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
58 Montravers P, Chalfine A, Gauzit R, Lepape A, Pierre Marmuse J, Vouillot C, Martin C. Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections. Ann Surg 2004;239:409-16. [PMID: 15075660 DOI: 10.1097/01.sla.0000114214.68169.e9] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
59 Pinar I, Abdul-Wahid W, Fransgaard T, Gögenur I. Association between Abdominal Free Fluid and Postoperative Complications and Mortality in Patients with Small-Bowel Obstruction. Scand J Surg 2019;108:36-41. [PMID: 29756508 DOI: 10.1177/1457496918772372] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
60 Bochud PY, Bonten M, Marchetti O, Calandra T. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32:S495-512. [PMID: 15542958 DOI: 10.1097/01.ccm.0000143118.41100.14] [Cited by in Crossref: 120] [Cited by in F6Publishing: 29] [Article Influence: 7.1] [Reference Citation Analysis]
61 Biedenbach DJ, Bouchillon SK, Hoban DJ, Hackel M, Phuong DM, Nga TT, Phuong NT, Phuong TT, Badal RE. Antimicrobial susceptibility and extended-spectrum beta-lactamase rates in aerobic gram-negative bacteria causing intra-abdominal infections in Vietnam: report from the Study for Monitoring Antimicrobial Resistance Trends (SMART 2009-2011). Diagn Microbiol Infect Dis 2014;79:463-7. [PMID: 24923210 DOI: 10.1016/j.diagmicrobio.2014.05.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
62 Byrnes MC, Schuerer DJE, Schallom ME, Sona CS, Mazuski JE, Taylor BE, Mckenzie W, Thomas JM, Emerson JS, Nemeth JL, Bailey RA, Boyle WA, Buchman TG, Coopersmith CM. Implementation of a mandatory checklist of protocols and objectives improves compliance with a wide range of evidence-based intensive care unit practices: . Critical Care Medicine 2009;37:2775-81. [DOI: 10.1097/ccm.0b013e3181a96379] [Cited by in Crossref: 91] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
63 Baré M, Castells X, Garcia A, Riu M, Comas M, Egea MJG. Importance of appropriateness of empiric antibiotic therapy on clinical outcomes in intra-abdominal infections. Int J Technol Assess Health Care 2006;22:242-8. [DOI: 10.1017/s0266462306051063] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
64 Brook I. Spectrum and treatment of anaerobic infections. J Infect Chemother 2016;22:1-13. [PMID: 26620376 DOI: 10.1016/j.jiac.2015.10.010] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
65 Namias N, Meizoso JP, Livingston DH; SOSICK Investigators Group. Survey of surgical infections currently known (SOSICK): a multicenter examination of antimicrobial use from the surgical infection society scientific studies committee. Surg Infect (Larchmt) 2008;9:509-14. [PMID: 18687044 DOI: 10.1089/sur.2007.078] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
66 Chen Z, Wu J, Zhang Y, Wei J, Leng X, Bi J, Li R, Yan L, Quan Z, Chen X, Yu Y, Wu Z, Liu D, Ma X, Maroko R, Cooper A. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial. BMC Infect Dis 2010;10:217. [PMID: 20663130 DOI: 10.1186/1471-2334-10-217] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
67 Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, Dipiro JT, Buchman T, Dellinger EP, Jernigan J, Gorbach S, Chow AW, Bartlett J. Guidelines for the Selection of Anti-infective Agents for Complicated Intra-abdominal Infections. Clinical Infectious Diseases 2003;37:997-1005. [DOI: 10.1086/378702] [Cited by in Crossref: 366] [Cited by in F6Publishing: 272] [Article Influence: 19.3] [Reference Citation Analysis]
68 Barie PS, Rotstein OD, Dellinger EP, Grasela TH, Walawander CA. The cost-effectiveness of cefepime plus metronidazole versus imipenem/cilastatin in the treatment of complicated intra-abdominal infection. Surg Infect (Larchmt) 2004;5:269-80. [PMID: 15684798 DOI: 10.1089/sur.2004.5.269] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
69 Sartelli M, Catena F, Di Saverio S, Ansaloni L, Malangoni M, Moore EE, Moore FA, Ivatury R, Coimbra R, Leppaniemi A, Biffl W, Kluger Y, Fraga GP, Ordonez CA, Marwah S, Gerych I, Lee JG, Tranà C, Coccolini F, Corradetti F, Kirkby-Bott J. Current concept of abdominal sepsis: WSES position paper. World J Emerg Surg 2014;9:22. [PMID: 24674057 DOI: 10.1186/1749-7922-9-22] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
70 Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, Chang PK, O'Neill PJ, Mollen KP, Huston JM, Diaz JJ Jr, Prince JM. The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surg Infect (Larchmt). 2017;18:1-76. [PMID: 28085573 DOI: 10.1089/sur.2016.261] [Cited by in Crossref: 201] [Cited by in F6Publishing: 152] [Article Influence: 40.2] [Reference Citation Analysis]
71 Maa J, Kirkwood KS. The Appendix. Sabiston Textbook of Surgery. Elsevier; 2012. pp. 1279-93. [DOI: 10.1016/b978-1-4377-1560-6.00051-2] [Cited by in Crossref: 8] [Article Influence: 0.8] [Reference Citation Analysis]
72 An MM, Zou Z, Shen H, Zhang JD, Chen ML, Liu P, Wang R, Jiang YY. Ertapenem versus piperacillin/tazobactam for the treatment of complicated infections: a meta-analysis of randomized controlled trials. BMC Infect Dis 2009;9:193. [PMID: 19951447 DOI: 10.1186/1471-2334-9-193] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
73 Martin GJ, Dunne JR, Cho JM, Solomkin JS; Prevention of Combat-Related Infections Guidelines Panel. Prevention of infections associated with combat-related thoracic and abdominal cavity injuries. J Trauma 2011;71:S270-81. [PMID: 21814093 DOI: 10.1097/TA.0b013e318227adae] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
74 Catena F, Vallicelli C, Ansaloni L, Sartelli M, Di Saverio S, Schiavina R, Pasqualini E, Amaduzzi A, Coccolini F, Cucchi M, Lazzareschi D, Baiocchi GL, Pinna AD. T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam. BMC Gastroenterol 2013;13:76. [PMID: 23631512 DOI: 10.1186/1471-230X-13-76] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
75 Herzog T, Chromik AM, Uhl W. Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria. Eur J Med Res 2010;15:525-32. [PMID: 21163727 DOI: 10.1186/2047-783x-15-12-525] [Cited by in Crossref: 27] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
76 Seguin P, Brianchon C, Launey Y, Laviolle B, Nesseler N, Donnio PY, Malledant Y. Are enterococci playing a role in postoperative peritonitis in critically ill patients? Eur J Clin Microbiol Infect Dis. 2012;31:1479-1485. [PMID: 22076551 DOI: 10.1007/s10096-011-1467-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
77 Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, Schorr C, Simpson S, Wiersinga WJ, Alshamsi F, Angus DC, Arabi Y, Azevedo L, Beale R, Beilman G, Belley-Cote E, Burry L, Cecconi M, Centofanti J, Coz Yataco A, De Waele J, Dellinger RP, Doi K, Du B, Estenssoro E, Ferrer R, Gomersall C, Hodgson C, Møller MH, Iwashyna T, Jacob S, Kleinpell R, Klompas M, Koh Y, Kumar A, Kwizera A, Lobo S, Masur H, McGloughlin S, Mehta S, Mehta Y, Mer M, Nunnally M, Oczkowski S, Osborn T, Papathanassoglou E, Perner A, Puskarich M, Roberts J, Schweickert W, Seckel M, Sevransky J, Sprung CL, Welte T, Zimmerman J, Levy M. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 2021;47:1181-247. [PMID: 34599691 DOI: 10.1007/s00134-021-06506-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 12.0] [Reference Citation Analysis]
78 Namias N, Solomkin JS, Jensen EH, Tomassini JE, Abramson MA. Randomized, Multicenter, Double-Blind Study of Efficacy, Safety, And Tolerability of Intravenous Ertapenem Versus Piperacillin/Tazobactam in Treatment of Complicated Intra-Abdominal Infections in Hospitalized Adults. Surgical Infections 2007;8:15-28. [DOI: 10.1089/sur.2006.030] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
79 Coccolini F, Catena F, Ansaloni L, Ercolani G, Di Saverio S, Gazzotti F, Lazzareschi D, Pinna AD. A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapenem vs three days Ampicillin-sulbactam). BMC Gastroenterol 2011;11:42. [PMID: 21501482 DOI: 10.1186/1471-230X-11-42] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
80 Mazuski JE. Clinical Challenges and Unmet Needs in the Management of Complicated Intra-abdominal Infections. Surgical Infections 2005;6:s-49-69. [DOI: 10.1089/sur.2005.6.s-49] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]